HOUSTON, TX, April 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN), a leading developer of dietary supplements, is pleased to announce a one-year advertising contract for display on airport and healthcare TV by ClearTV Media USA.
ClearTV Media operates broadcast television networks installed in select away-from-home venues where people endure lengthy wait times and are reached effectively with engaging, in-demand, short-form programming and commercial advertisements.
ClearTV Media favors venues where dwells are lengthy and meaningful consumer engagement is possible. This requires programming to be genuinely compelling and of real interest to the viewer; entertainment-centric programming is the focus. The Company currently operates in airports and healthcare locations and offers on-line digital video syndication.
“We are very pleased with our new advertising venue that we expect will accelerate sales of our StemStrength Deluxe AM & PM for men and women,” said Alex Blankenship, President of AngioSoma. “The greater visibility for offering our supplements for sale to the public is a meaningful step forward.”
ABOUT ANGIOSOMA, INC.
AngioSoma, Inc. (https://angiosoma.com), a Nevada corporation based in Houston, Texas, is dedicated to improving the mental and physical wellbeing of men and women. To accomplish that purpose, we have launched a new e-commerce website to market our line of supplements under our SomaCeuticals™ common identity. Our supplements cover three industry segments: nutraceuticals, cosmeceuticals, and pharmaceuticals.
The agreement with ClearTV will direct prospective purchasers to our website http://soma-ceuticals.com where products can be ordered for free delivery.
NOTICE REGARDING FORWARD LOOKING STATEMENTS
This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.
CONTACT
AngioSoma, Inc.
Alex Blankenship
investors@AngioSoma.com
(832) 781-8521